JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response

  • 0Institute of Endotypes in Oncology, Metabolism and Immunology (IEOMI) "G. Salvatore", National Research Council (CNR), S. Pansini 5, 80131 Naples, Italy.
Genes +

|

April 26, 2025

|

April 26, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

UbcH10 protein may influence non-small cell lung cancer (NSCLC) treatment response to tyrosine kinase inhibitors (TKIs). Its expression, potentially regulated by p53 and EGFR, might affect patient survival and TKI resistance.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • UbcH10 protein is implicated in various human cancers.
  • UbcH10 is overexpressed in non-small cell lung cancer (NSCLC) and correlates with p53 and EGFR mutational status.

Purpose Of The Study

  • To investigate the role of UbcH10 in NSCLC.
  • To explore the relationship between UbcH10, EGFR, p53, and tyrosine kinase inhibitor (TKI) response.

Main Methods

  • Transfection of lung cancer cells with EGFR variants.
  • Modulation of UbcH10 and p53 expression.
  • Western blotting and immunohistochemistry.
  • Treatment with TKI erlotinib.

Main Results

  • EGFR overexpression potentially modulates UbcH10 expression via p53.
  • Increased UbcH10 expression in mutant EGFR cells suggested erlotinib resistance.
  • UbcH10 levels in NSCLC patients correlated with progression-free survival.

Conclusions

  • UbcH10 may regulate TKI response in NSCLC through a pathway involving p53 and EGFR.
  • Further research is required to elucidate the precise mechanism.

Keywords:

Related Concept Videos

Mitogens and the Cell Cycle 02:38

6.3K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation 02:23

4.3K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Interactions Between Signaling Pathways 01:19

6.1K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...